Merck receives USFDA approval for Ebola vaccine
Updated : December 20, 2019 08:22 AM IST
The US Food and Drug Administration said on Thursday it granted approval to drugmaker Merck & Co's Ebola vaccine Ervebo, making it the first FDA-approved vaccine against the deadly virus.
The vaccine was used by the World Health Organization and Democratic Republic of the Congo as an investigational vaccine to help reduce Ebola virus disease (EVD) outbreaks in few West African countries from 2014 to 2016.
Published : December 20, 2019 08:22 AM IST